Intas Pharmaceuticals Ltd. - nicht nehmen, doppelt We are a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Our success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R & D, Biotechnology and global operations over three decades. Today, we are a $350 million organization with overall 35% CAGR growth over the last 4 years and is ranked as the 12th largest pharmaceutical company in the domestic market. (as per IMS Health India, Secondary Stockist Audit (SSA), April 2011) In the domestic market, we are one of the leading players in chronic therapy areas, also having presence in central nervous system (CNS), cardiovascular system (CVS), diabetology, gastroenterology and pain management. Recently, the company has extended its presence into other therapy areas such as gynecology, infertility and respiratory care. Besides growing domestic dominance, we are also present in over 50 countries worldwide and have made successful forays into contract manufacturing and contract marketing tie-ups across the world predominantly in North America, Europe & Latin America. Our global strategy includes alliances with leading Global Pharma Companies for development and distribution of products as well as direct product distribution. Its subsidiary has made substantial investments in the development, manufacturing and marketing of products based on biotechnology (biosimilars) in chronic therapy areas including oncology and nephrology. Continual R & D initiatives have strengthened niche and complex product offerings in India and International markets. Commercialized in India, three pharmaceutical formulations are based on the novel lipid based drug delivery system with studies ongoing to extend these products to International markets. We have made strategic investments in ten manufacturing facilities, globally. Between them, these facilities have received approvals from various prominent international regulatory bodies, including U.S. Food and Drug Administration (FDA).